Hyris Archives | Be Korea-savvy
Hyris’ New T-Cell Test is Finally Available to EU Countries to Easily Map Patients’ Cellular Immunity to SARS-CoV-2

Hyris’ New T-Cell Test is Finally Available to EU Countries to Easily Map Patients’ Cellular Immunity to SARS-CoV-2

LONDON, Aug. 5 (Korea Bizwire) — As the pandemic crisis has entered a new phase, it is a common belief among the scientific community that COVID-19 is here to stay, maybe for a long time. Many scientists expect the virus that causes COVID-19 to become endemic. According to a 2021 Nature’s poll, administered to more [...]

A New T-Cell Activation Assay Based on Hyris qPCR Technology Marks a Disruptive Approach for the Detection of SARS-CoV-2 Specific Cellular Immunity

A New T-Cell Activation Assay Based on Hyris qPCR Technology Marks a Disruptive Approach for the Detection of SARS-CoV-2 Specific Cellular Immunity

LONDON, June 15 (Korea Bizwire) — With over 460 million global cases thus far, 6 million of which have resulted in death, the COVID-19 pandemic from SARS-CoV-2 proved to be a dire health crisis on a global scale. In this concerning scenario, the unprecedented effort by the international scientific community is even more remarkable and led [...]

Hyris Fully Embraces the Immunology Sector to Better Fight COVID-19 and Beyond, Presenting Its New, Disruptive T-Cell Test to the International Conference ‘A-Wish’

Hyris Fully Embraces the Immunology Sector to Better Fight COVID-19 and Beyond, Presenting Its New, Disruptive T-Cell Test to the International Conference ‘A-Wish’

LONDON, Dec. 15 (Korea Bizwire) — As the COVID-19 pandemic keeps causing concerns, with new variants spreading worldwide, it is now widely recognized that we must move beyond a “test&trace” only approach. World leaders and health institutions today aim to achieve high immunity rates among the population, facing the unprecedented challenge of a worldwide vaccination campaign against an emerging [...]

Hyris Brings to Market Worldwide a New Test That Can Quickly Detect the Body’s T-Cell Immune Response to SARS-CoV-2, Thanks to a Partnership with Singapore’s Duke-NUS Medical

Hyris Brings to Market Worldwide a New Test That Can Quickly Detect the Body’s T-Cell Immune Response to SARS-CoV-2, Thanks to a Partnership with Singapore’s Duke-NUS Medical

LONDON, Oct. 14 (Korea Bizwire) — After almost two years of fight against COVID-19, governments, NGOs, and corporations are now focusing on strategies and solutions to boost population immunity and move onto the next phase – possibly out of the pandemic. Hyris, a global, innovation-based biotechnology company renowned for its inclusive approach to genetic analysis, [...]

The Hyris System™ Detects SARS-CoV-2, Including Recently Emerged Variants of Concerns

The Hyris System™ Detects SARS-CoV-2, Including Recently Emerged Variants of Concerns

LONDON, England, Sept. 14 (Korea Bizwire) — New mutations of SARS-CoV-2 worldwide are causing several concerns regarding further disruption of public safety. Authorities involved in the fight against COVID-19, such as the WHO, the CDC, and the ECDC, identify these mutations as Variants of Concern based on their risk assessment and monitor them, increasing the level of awareness amongst [...]